Displaying 13 - 24 items out of 29 results
Press release
… reported data from the KEYNOTE 021 trial that showed antitumor activity for pembrolizumab plus platinum-based … and pemetrexed or carboplatin and pemetrexed alone. Tumor mutational burden was determined by whole exome sequencing of tumor and matched normal DNA. Langer and the KEYNOTE 021 researchers were able to …
ILCN article
Gender Disparity in Lung Cancer
… 2 Jyoti Patel, MD For example, germline mutations in tumor suppressor genes such as TP53, DNA repair pathway genes such as BRCA1, BRCA2, and … these emerging survival patterns, including differences in tumor biology discussed above as well as treatment response …
Press release
… laboratory projects focus on the clonal evolution of tumors, cell-free plasma DNA as biomarkers for early detection, and the role of …
Landing page
… non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation … Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid …
Press release
… biology and its evolution over time, using tools like circulating tumour DNA from liquid biopsies, to match patients to the adjuvant … a targeted therapy,” she stated. “The possibility to study circulating tumour cells from blood samples has been a …
Landing page
… Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation … work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid …
Landing page
… liquid biopsies, specifically in extracellular vesicles and circulating free tumor DNA. Dr. Rolfo has authored more than 250 scientific …
Landing page
… Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation … work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid …
Landing page
… of lung cancers harboring mutations in genes involved in DNA damage repair (DDR) derive improved clinical … of the interaction of metabolite-miRNA in driving tumor initiation. Read Spotlight Grant Recipient Hua Zhang, …
ILCN article
Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data
… of surgery in the treatment of malignant mesothelioma began circulating. And after a debate at the 2024 Targeted … mesothelioma is maximal cytoreduction to remove all visible tumor, but an R0 resection is not possible. Surgery alone is …